Cargando…

Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy

The association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaohao, Wu, Yunzi, Zheng, Li, Xue, Liyan, Jiang, Zhichao, Wang, Chenfeng, Xie, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350511/
https://www.ncbi.nlm.nih.gov/pubmed/34381707
http://dx.doi.org/10.3389/fonc.2021.671474
_version_ 1783735777629306880
author Zheng, Xiaohao
Wu, Yunzi
Zheng, Li
Xue, Liyan
Jiang, Zhichao
Wang, Chenfeng
Xie, Yibin
author_facet Zheng, Xiaohao
Wu, Yunzi
Zheng, Li
Xue, Liyan
Jiang, Zhichao
Wang, Chenfeng
Xie, Yibin
author_sort Zheng, Xiaohao
collection PubMed
description The association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinical, and pathological information of 247 stage II gastric cancer patients who underwent radical D2 gastrectomy in our department between January 2011 and December 2014 were collected and retrospectively analyzed. The relationship between and long-term clinical outcomes of stage II gastric cancer was analyzed using t-tests, chi-square tests, receiver operating characteristic (ROC) analysis, time-dependent ROC analysis, K–M curves, and a Cox regression model. The median follow-up of 247 stage II gastric cancer patients was 5.49 years (range: 0.12–8.62 years). The Kaplan–Meier estimated 3-year and 5-year DSS rates of the study group were 92.7% (95% CI 89.4–95.9) and 88.7% (95% CI 84.7–92.7), respectively. Higher age (>70 vs. ≤70, log-rank p = 0.0406), nerve invasion (positive vs. negative, log-rank p = 0.0133), and non-distal gastrectomy (distal partial gastrectomy vs. other surgical methods, log-rank p = 0.00235) had worse prognoses compared to controls. Univariate and multivariate analyses of disease-specific survival showed that these three factors were independent prognostic factors for patients with stage II disease. The area under time-dependent ROC curve (AUC) is 0.748 of 5-year survival and c-index is 0.696 based on the three-marker model drawn for stage II patients. Subgroup analyses showed an interaction between tumor location and nerve invasion. The age, perineural invasion, and surgical approach are independent prognostic factors for disease-specific survival after radical gastrectomy. Tumor location may be an important confounding factor for outcomes by affecting surgical methods and the hazards of nerve invasion.
format Online
Article
Text
id pubmed-8350511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83505112021-08-10 Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy Zheng, Xiaohao Wu, Yunzi Zheng, Li Xue, Liyan Jiang, Zhichao Wang, Chenfeng Xie, Yibin Front Oncol Oncology The association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinical, and pathological information of 247 stage II gastric cancer patients who underwent radical D2 gastrectomy in our department between January 2011 and December 2014 were collected and retrospectively analyzed. The relationship between and long-term clinical outcomes of stage II gastric cancer was analyzed using t-tests, chi-square tests, receiver operating characteristic (ROC) analysis, time-dependent ROC analysis, K–M curves, and a Cox regression model. The median follow-up of 247 stage II gastric cancer patients was 5.49 years (range: 0.12–8.62 years). The Kaplan–Meier estimated 3-year and 5-year DSS rates of the study group were 92.7% (95% CI 89.4–95.9) and 88.7% (95% CI 84.7–92.7), respectively. Higher age (>70 vs. ≤70, log-rank p = 0.0406), nerve invasion (positive vs. negative, log-rank p = 0.0133), and non-distal gastrectomy (distal partial gastrectomy vs. other surgical methods, log-rank p = 0.00235) had worse prognoses compared to controls. Univariate and multivariate analyses of disease-specific survival showed that these three factors were independent prognostic factors for patients with stage II disease. The area under time-dependent ROC curve (AUC) is 0.748 of 5-year survival and c-index is 0.696 based on the three-marker model drawn for stage II patients. Subgroup analyses showed an interaction between tumor location and nerve invasion. The age, perineural invasion, and surgical approach are independent prognostic factors for disease-specific survival after radical gastrectomy. Tumor location may be an important confounding factor for outcomes by affecting surgical methods and the hazards of nerve invasion. Frontiers Media S.A. 2021-07-26 /pmc/articles/PMC8350511/ /pubmed/34381707 http://dx.doi.org/10.3389/fonc.2021.671474 Text en Copyright © 2021 Zheng, Wu, Zheng, Xue, Jiang, Wang and Xie https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zheng, Xiaohao
Wu, Yunzi
Zheng, Li
Xue, Liyan
Jiang, Zhichao
Wang, Chenfeng
Xie, Yibin
Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_full Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_fullStr Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_full_unstemmed Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_short Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_sort disease-specific survival of ajcc 8th stage ii gastric cancer patients after d2 gastrectomy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350511/
https://www.ncbi.nlm.nih.gov/pubmed/34381707
http://dx.doi.org/10.3389/fonc.2021.671474
work_keys_str_mv AT zhengxiaohao diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT wuyunzi diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT zhengli diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT xueliyan diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT jiangzhichao diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT wangchenfeng diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT xieyibin diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy